GO
Loading...

Baxter International Inc

More

  • Best Trades Now: Healthcare, Energy & More Wednesday, 16 Jul 2008 | 12:40 PM ET

    To give investors an edge, CNBC asked the experts for their best stock picks now.

  • Bear Market Band-Aid Tuesday, 15 Jul 2008 | 6:26 PM ET

    You’ve gotta’ love modern medicine. Not only does it cure stomach upset now it may be the best remedy for what ails your portfolio.

  • Recession Guide - BDX Wednesday, 9 Jul 2008 | 6:20 PM ET

    With our economy struggling under the weight of multiple potential large bank failures, with high oil prices, high food prices—you name it—financially strangling indiviuals and companies alike, you need the Cramerican Marine Field Guide to recessions if you want to try and make money in this market.

  • German health care group Fresenius plans to buy APP Pharmaceuticals in a $3.7 billion deal to expand into the North American intravenous generic drugs market.

  • The Week in Review:  Looking Up In a Down Market Saturday, 21 Jun 2008 | 8:41 AM ET

    Almost everywhere they looked during the week, investors saw red ink flowing. But CNBC guests worked hard to find bright spots in the murk.

  • Growing Your Profits With Ag, Healthcare & Pipelines Wednesday, 18 Jun 2008 | 2:51 PM ET

    To give investors an edge, CNBC asked the market experts for their best stock picks now.

  • Health Care Stocks: Schwab's Rx Wednesday, 18 Jun 2008 | 1:54 PM ET

    Shares of many health-care companies have been hit hard this year.  But Schwab's Paul Alan Davis says there are some promising opportunities.

  • Health Care Investing: Schwab's Rx Friday, 11 Apr 2008 | 12:39 PM ET

    "Health care" is two words -- and the health care sector is increasingly being viewed as two very different sectors:  pharmaceuticals and managed care, which are in trouble; and medical devices and services, which are not. Paul Alan Davis of Charles Schwab Investment Management offered advice for playing the sector(s).

  • Baxter, Biogen Idec & Elan Subjects of Broken Embargoes Wednesday, 5 Mar 2008 | 8:15 AM ET

    Embargoes imposed by scientific groups and medical journals will once again be put to the test over the next couple of months.

  • Goldman Sachs: The "Safe" Stocks For Primary Season Monday, 7 Jan 2008 | 4:20 PM ET

    Goldman Sachs analysts say stock investors should look to larger cap and defensive sectors as a way to play the uncertainty of presidential primary season. While they say the major party nominees should become clear by "Super Duper Tuesday," there is greater electoral and policy uncertainty in this Presidential race because there are no incumbents running.

  • Baxter Vs. Boston Scientific: Who's the Better Buy? Monday, 30 Apr 2007 | 7:00 PM ET

    What's the difference between a best of breed medical stock and one that's worst of breed? Let Cramer explain it to you.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • It's Time for the Lightning Round! Thursday, 8 Mar 2007 | 6:38 PM ET

    Today Cramer talks drilling stocks, MasterCard, Sprint and many, many more...